New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
about
Inflammatory bowel disease in Asia: A systematic reviewNovel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and PhenotypeNovel biomarkers of fibrosis in Crohn's diseaseEmerging role of novel biomarkers in the diagnosis of inflammatory bowel diseaseAntibody markers in the diagnosis of inflammatory bowel diseaseAutoantibodies and an immune-based rat model of inflammatory bowel diseaseNovel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodiesDifferential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectivesCharacterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysisRecent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?Seroreactivity against glycolytic enzymes in inflammatory bowel disease.Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndromeSerological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.Is the disease course predictable in inflammatory bowel diseases?Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease.New proteomic approaches for biomarker discovery in inflammatory bowel disease.The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy.Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease.Mycobiota in gastrointestinal diseases.Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn's disease.Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosisTargeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's diseaseCurrent and future role of biomarkers in Crohn's disease risk assessment and treatment.ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice.Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis.Predictors of aggressive inflammatory bowel disease.Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases.Biomarkers in inflammatory bowel disease: current practices and recent advances.Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease.Anticommensal Responses Are Associated with Regulatory T Cell Defect in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Patients.Increased levels of anti-glycan antibodies in patients with cystic fibrosis.Pediatric inflammatory bowel disease with cytoplasmic staining of antineutrophil cytoplasmic antibodiesEmerging inflammatory bowel disease in saudi outpatients: a report of 693 cases.Elastic scattering spectroscopy as an optical marker of inflammatory bowel disease activity and subtypes.Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.Current understanding of fungal microflora in inflammatory bowel disease pathogenesis
P2860
Q22242420-AC6BF43E-2807-4510-BC1E-9856EA903ABCQ22251117-421BEA8A-383F-4D47-93EF-78E500B8EE2AQ26738287-9E0057CB-6B09-4850-ADA8-0BB8AF3FAB26Q26768273-A506D40B-17B1-4229-A90F-BE0183655BB0Q26774452-D4A7E418-24C0-47B6-A30E-3CC13595A8FAQ26822756-AF2DA832-E0A0-4319-A31E-2F3FFB4EDBEAQ27000411-04F3436F-1982-41A0-A02A-BA83FBEE28D3Q28085134-CF44365E-7BF1-463B-85BE-8089A7AFA24EQ28740412-6C771700-2B53-4AA3-87BE-B709479A35F9Q30242073-B6632C21-C036-4BE3-8482-DFFB91D0C893Q33632430-DD545F34-4417-4010-A1C7-CDB00FE9A9C5Q33718699-AE07227A-15B5-4E9C-98D9-92598981818EQ33761406-3037A180-FE8C-480A-B45D-3CBBCD2FC277Q33894191-49C91E54-1A2B-43BE-9630-D8FE41586AC9Q33894195-223C5669-EE4E-490E-8A3D-3A20D7BC1B64Q34096526-F7CA5ABF-7CAE-4A0A-A3C4-DF5C28E5C0FFQ34147687-C6F4CF24-2B71-4168-88EB-067CACCD66B9Q34258150-91D9791D-81C0-4B33-BDD9-A533A12266BBQ34367414-82409B4C-0B59-49FF-8A4F-EB6C120501F1Q34388523-5F6FA4D6-9A4E-4B83-80E7-3AF98F37FBACQ34447163-5D34F7A1-FF87-4C13-86D2-152BBF3FC467Q34976051-27A689CA-484F-4EEF-8C61-BC4C43E5B462Q35004592-3C77B0E6-BD24-4767-A15B-0F0E43174B2EQ35058495-ECEBAD1E-4CF4-4925-B9A2-22E81622C7F0Q35095265-B92CC17D-D54D-43E5-9F0E-4F95E7528A00Q35210622-B49B0F8F-C4C6-4913-A1F1-BEEE3AC688E8Q35381299-798A8FCC-1063-438E-94A4-63BFAEF04EAEQ35691407-368E9293-EED4-4308-A1DF-A908A67185A1Q35748693-A53CD887-F388-4E09-8A23-5AAD6CA99A4AQ35755268-F272B28F-E369-4416-8C57-F15BCF35FB9AQ35840853-883F1399-34D1-4EAF-B077-70C30B9CC3E2Q35890578-09BEF3A4-F27E-4DE3-976A-D43AEB1653EEQ35931810-D9D37F87-B31F-4C59-9376-91A19A583071Q35959693-AE6EA5F6-48B3-4C76-8956-8548E62E976EQ36651184-95A943EB-6702-423F-B73E-948890B42A4CQ36702482-F2752159-CA85-4EEE-A0C1-CCBFF77142C0Q36874416-19E1A841-198B-49B4-9F0E-32A609099171Q36994288-85785D78-EBF0-4ABB-BE53-EFDD1F817C15Q37064590-59E1C92F-7333-4C36-865D-815E1499D7E3Q37089171-ACC0EE03-DADC-4BD6-AF66-493DED147460
P2860
New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
New serological markers in inf ...... complicated disease behaviour
@ast
New serological markers in inf ...... complicated disease behaviour
@en
New serological markers in inf ...... complicated disease behaviour
@en-gb
New serological markers in inf ...... complicated disease behaviour
@nl
type
label
New serological markers in inf ...... complicated disease behaviour
@ast
New serological markers in inf ...... complicated disease behaviour
@en
New serological markers in inf ...... complicated disease behaviour
@en-gb
New serological markers in inf ...... complicated disease behaviour
@nl
prefLabel
New serological markers in inf ...... complicated disease behaviour
@ast
New serological markers in inf ...... complicated disease behaviour
@en
New serological markers in inf ...... complicated disease behaviour
@en-gb
New serological markers in inf ...... complicated disease behaviour
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
New serological markers in inf ...... complicated disease behaviour
@en
P2093
Gary L Norman
Liesbet Henckaerts
Marc Ferrante
Marie Pierik
Rom T Altstock
Sofie Joossens
P2860
P304
P3181
P356
10.1136/GUT.2006.108043
P407
P577
2007-10-01T00:00:00Z